0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Incidentally Detected Solitary Metastatic Melanoma of the Spleen Without Known Primary: A Case Report

      case-report
      1 , , 1 , 2 , 3
      ,
      Cureus
      Cureus
      skin cancer, metastatic melanoma, splenic mass, melanoma, splenic melanoma

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Splenic masses could be secondary to infection or due to benign and malignant cancers. Due to its anatomy and microenvironment, the spleen is relatively protected from cancer spread. However, melanomas are one of the few cancers that metastasize to the spleen, but only 2% of these metastasize as solitary splenic masses. Among such a small fraction, only a handful have been reported without a known primary.

          Our patient, an elderly male in his early 60s, was diagnosed with metastatic melanoma of the spleen following a biopsy of the incidentally detected isolated splenic mass. Complete ocular, oral, and dermatological inspections were unremarkable for a probable primary. He responded well to immunotherapy and total splenectomy with no recurrence.

          Due to advanced imaging modalities in the modern era, the probability of isolated splenic masses as an initial presentation will increase, and a high index of clinical suspicion should be maintained for metastatic cancer as one of the differentials.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: not found

          Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

          New England Journal of Medicine, 373(1), 23-34
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway

              There have been major advances in the understanding of melanoma since the last revision of the World Health Organization (WHO) classification in 2006. To discuss development of the 9 distinct types of melanoma and distinguishing them by their epidemiology, clinical and histologic morphology, and genomic characteristics. Each melanoma subtype is placed at the end of an evolutionary pathway that is rooted in its respective precursor, wherever appropriate and feasible, based on currently known data. Each precursor has a variable risk of progression culminating in its fully evolved, invasive melanoma. This review is based on the “Melanocytic Tumours” section of the 4th edition of the WHO Classification of Skin Tumours, published in 2018. Melanomas were divided into those etiologically related to sun exposure and those that are not, as determined by their mutational signatures, anatomic site, and epidemiology. Melanomas on the sun-exposed skin were further divided by the histopathologic degree of cumulative solar damage (CSD) of the surrounding skin, into low and high CSD, on the basis of degree of associated solar elastosis. Low-CSD melanomas include superficial spreading melanomas and high-CSD melanomas incorporate lentigo maligna and desmoplastic melanomas. The “nonsolar” category includes acral melanomas, some melanomas in congenital nevi, melanomas in blue nevi, Spitz melanomas, mucosal melanomas, and uveal melanomas. The general term melanocytoma is proposed to encompass “intermediate” tumors that have an increased (though still low) probability of disease progression to melanoma.
                Bookmark

                Author and article information

                Journal
                Cureus
                Cureus
                2168-8184
                Cureus
                Cureus (Palo Alto (CA) )
                2168-8184
                4 May 2023
                May 2023
                : 15
                : 5
                : e38530
                Affiliations
                [1 ] Internal Medicine, Saint Vincent Hospital, Worcester, USA
                [2 ] Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, USA
                [3 ] Hematology and Oncology, Saint Vincent Hospital, Worcester, USA
                Author notes
                Article
                10.7759/cureus.38530
                10166280
                5f58489c-4654-4945-ba67-8e2cde5357be
                Copyright © 2023, Arun Kumar et al.

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 4 May 2023
                Categories
                Dermatology
                Internal Medicine
                Oncology

                skin cancer,metastatic melanoma,splenic mass,melanoma,splenic melanoma

                Comments

                Comment on this article